Skip to main content

Aeolus Pharmaceuticals Inc. (AOLS)

OTCMKTS: AOLS · Delayed Price · USD
0.0008 0.0000 (0.00%)
Sep 24, 2021 4:00 PM EDT - Market closed
Market Cap121,668
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out152.09M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.0000
Previous Close0.0008
Day's Range0.0008 - 0.0008
52-Week Range0.0008 - 0.0200
Beta2.52
Analystsn/a
Price Targetn/a
Earnings Daten/a

About AOLS

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which ...

IndustryPharmaceuticals
IPO DateFeb 1, 1996
CEOJohn McManus
Employees4
Stock ExchangeOTCMKTS
Ticker SymbolAOLS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.